GOLDMAN SACHS GROUP INC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2022$39,000
-11.4%
17,473
-17.3%
0.00%
Q2 2022$44,000
-47.6%
21,122
-27.2%
0.00%
Q1 2022$84,000
-12.5%
29,025
-3.4%
0.00%
Q4 2021$96,000
-40.0%
30,041
-33.5%
0.00%
Q3 2021$160,000
-33.3%
45,163
-40.3%
0.00%
Q2 2021$240,000
-10.8%
75,646
-3.2%
0.00%
Q1 2021$269,000
+83.0%
78,139
+34.1%
0.00%
Q4 2020$147,000
-23.0%
58,278
-35.7%
0.00%
Q3 2020$191,000
-25.7%
90,675
-21.0%
0.00%
Q2 2020$257,000
+65.8%
114,712
+87.2%
0.00%
Q1 2020$155,000
+23.0%
61,294
+27.2%
0.00%
Q4 2019$126,000
-3.8%
48,183
+32.4%
0.00%
Q3 2019$131,000
-67.7%
36,403
-69.7%
0.00%
Q2 2019$406,000
+75.8%
120,326
+42.3%
0.00%
Q1 2019$231,000
-18.9%
84,560
-17.5%
0.00%
Q4 2018$285,000
-25.6%
102,467
+10.3%
0.00%
Q3 2018$383,000
-41.3%
92,880
-26.2%
0.00%
Q2 2018$653,000
-46.0%
125,915
-43.0%
0.00%
Q1 2018$1,210,000
-0.9%
220,814
+47.4%
0.00%
Q4 2017$1,221,000
-18.3%
149,854
+5.1%
0.00%
Q3 2017$1,494,000
-34.4%
142,623
-30.8%
0.00%
-100.0%
Q2 2017$2,277,000
+127.5%
206,234
+72.4%
0.00%
Q1 2017$1,001,000
+14.0%
119,639
-5.4%
0.00%
Q4 2016$878,000
+53.8%
126,524
+12.9%
0.00%
Q3 2016$571,000
+178.5%
112,099
+225.9%
0.00%
Q2 2016$205,000
-74.1%
34,396
-80.2%
0.00%
Q1 2016$790,000
+65.3%
173,561
+63.4%
0.00%
Q4 2015$478,000
+8.4%
106,239
-23.6%
0.00%
Q3 2015$441,000
-52.1%
138,977
-54.3%
0.00%
Q2 2015$921,000
+254.2%
303,999
+245.3%
0.00%
Q1 2015$260,000
-27.6%
88,044
+8.8%
0.00%
Q4 2014$359,000
-23.6%
80,918
-11.2%
0.00%
Q3 2014$470,000
-10.6%
91,173
-9.1%
0.00%
Q2 2014$526,000
-4.9%
100,278
-24.6%
0.00%
Q1 2014$553,000
+27.7%
132,978
-10.3%
0.00%
Q4 2013$433,000
+1.9%
148,329
-12.0%
0.00%
Q3 2013$425,000
+20.7%
168,583
-0.4%
0.00%
Q2 2013$352,000
-28.7%
169,211
-7.5%
0.00%
Q4 2012$494,000
-2.2%
182,850
-26.2%
0.00%
Q3 2012$505,000
+11.2%
247,761
-8.8%
0.00%
Q2 2012$454,000
+1465.5%
271,768
+2430.0%
0.00%
Q1 2012$29,00010,7420.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders